What the six lenses say about JLHL — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How JLHL’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.1pp | -2.2pp | -7.1pp | -81.4pp | -74.6pp | -76.0pp |
Nifty 500 Broad-market baseline | +0.1pp | -2.2pp | -8.2pp | -83.0pp | -80.4pp | -81.2pp |
Sector Own-sector index | — | — | -9.5pp | -85.7pp | -89.1pp | -94.5pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
JLHL daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
JLHL ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 287 | 323 | 321 | 337 | 353 | 394 | 365 | 388 |
| ↳ change QoQ | — | +12.3% | -0.6% | +5.1% | +4.7% | +11.6% | -7.4% | +6.3% |
| EBITDA (₹cr) | 72 | 84 | 83 | 80 | 78 | 92 | 83 | 89 |
| EBITDA margin | 25.1% | 26.2% | 26.0% | 23.7% | 22.1% | 23.4% | 22.7% | 22.9% |
| PAT (₹cr) | 45 | 52 | 53 | 45 | 44 | 57 | 42 | 50 |
| ↳ change QoQ | — | +15.5% | +2.0% | -14.3% | -2.2% | +29.5% | -26.3% | +19.0% |
| Net margin | 15.5% | 16.0% | 16.4% | 13.4% | 12.5% | 14.5% | 11.5% | 12.9% |
| EPS (₹) | 6.80 | 7.86 | 8.01 | 6.89 | 6.69 | 8.75 | 6.49 | 7.66 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding JLHL (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| SBI Multicap Reg Gr | 2.75% | 24,147 | |
| Aditya BSL Multi-Cap Reg Gr | 0.89% | 7,182 | |
| SBI Healthcare Opportunities Reg Gr | 2.88% | 5,400 | |
| HDFC Pharma and Healthcare Reg Gr | 2.45% | 2,940 | |
| UTI Healthcare Reg Gr | 2.18% | 1,371 | |
| Aditya BSL Pharma & Hlthcare Reg Gr | 2.03% | 1,074 | |
| HDFC Consumption Reg Gr | 1.73% | 1,033 | |
| WhiteOak Capital Phrm and Hlthcr Reg Gr | 1.07% | 825 | |
| PGIM India Healthcare Reg Gr | 2.23% | 112 | |
| The Wealth Company Small Cap Dirt Gr | 2.56% | 106 |
ETFs holding JLHL (1)
| ETF | Weight | Grade |
|---|---|---|
| Groww BSE Hospitals ETF | 2.51% |